Relationship between Types of Serum Antibodies Against H.pylori and Gastric Diseases
1.Department of Gastroenterology/Guangzhou Center of Digestive Diseases,Guangzhou First People's Hospital,Guangzhou Medical University,Guangzhou 510180,China
2.School of Public Health,Guangzhou Medical University,Guangzhou 510000,China
*Corresponding author:LIN Yong,Associate chief physician;E-mail:lysky163@163.com
[1]刘文忠.“第五次全国幽门螺杆菌感染处理共识报告”解读[J].胃肠病学,2017,22(6):321-324.DOI:10.3969/j.issn.1008-7125.2017.06.001.
LIU W Z.Interpretation of the fifth Chinese national consensus report on management of Helicobacter pylori infection[J].Chin J Gastroenterol,2017,22(6):321-324.DOI:10.3969/j.issn.1008-7125.2017.06.001.
[2]NAGY P,JOHANSSON S,MOLLOY-BLAND M.Systematic review of time trends in the prevalence of Helicobacter pylori infection in China and the USA[J].Gut Pathog,2016,8:8.DOI:10.1186/s13099-016-0091-7.
[3]NELL S,ESTIBARIZ I,KREBES J,et al.Genome and methylome variation in Helicobacter pylori with a cag pathogenicity island during early stages of human infection[J].Gastroenterology,2018,154(3):612-623.e7.DOI:10.1053/j.gastro.2017.10.014.
[4]SZKARADKIEWICZ A,KARPINSKI T M,LINKE K,et al.Expression of cagA,virB/D complex and/or VacA genes in Helicobacter pylori strains originating from patients with gastric diseases[J].PLoS One,2016,11(2):e0148936.DOI:10.1371/journal.pone.0148936.
[5]杨成,崔梅花.幽门螺杆菌致病因子及其致病机制研究进展[J].世界华人消化杂志,2017,25(10):857-864.
YANG C,CUI M H.Virulence factors and pathogenic mechanism of Helicobacter pylori[J].World Chin J Dig,2017,25(10):857-864.
[6]徐佳升,王彪,谢川.幽门螺杆菌菌株特异性与胃癌关系研究进展[J].中国全科医学,2018,21(18):2258-2262,2268.DOI:10.3969/j.issn.1007-9572.2018.00.120.
XU J S,WANG B,XIE C.Advances in the association of Helicobacter pylori strain specificity with gastric cancer[J].Chinese General Practice,2018,21(18):2258-2262,2268.DOI:10.3969/j.issn.1007-9572.2018.00.120.
[7]OGIWARA H,GRAHAM D Y,YAMAOKA Y.VacA I-region subtyping[J].Gastroenterology,2008,134(4):1267; author reply 1268.DOI:10.1053/j.gastro.2007.11.062.
[8]LEUNG W K,WONG I O L,CHEUNG K S,et al.Effects of Helicobacter pylori treatment on incidence of gastric cancer in older individuals[J].Gastroenterology,2018,155(1):67-75.DOI:10.1053/j.gastro.2018.03.028.
[9]周海娟.上消化道疾病患者幽门螺杆菌感染现状分析[J].中外医学研究,2016,14(21):139-141.DOI:10.14033/j.cnki.cfmr.2016.21.076.
ZHOU H J.Current status analysis of Helicobacter pylori infection in patients with upper gastrointestinal disease[J].Chin Foreign Med Res,2016,14(21):139-141.DOI:10.14033/j.cnki.cfmr.2016.21.076.
[10]黄曼玲,孙圣斌,徐丹,等.幽门螺杆菌感染与胃镜下的不同胃炎及病理之间的关系[J].实用医学杂志,2014,30(14):2245-2247.
[11]THJODLEIFSSON B,ASBJ?RNSDOTTIR H,SIGURJONSDOTTIR R B,et al.Seroprevalence of Helicobacter pylori and cagA antibodies in Iceland,Estonia and Sweden[J].Scand J Infect Dis,2007,39(8):683-689.DOI:10.1080/00365540701225736.
[12]崔建鹏,周力.应用免疫印迹法探讨血清幽门螺杆菌抗体谱与上消化道疾病的关系[J].中国医学创新,2014,11(24):28-30.
CUI J P,ZHOU L.Discussion of the relationship between the serum Helicobacter pylori antibody spectrum and the disease of upper digestive tract using Western blot[J].Med Innov China,2014,11(24):28-30.
[13]陈力,张成栋,殷洁,等.青岛地区胃黏膜病变患者幽门螺杆菌及其相关抗体的分析[J].胃肠病学和肝病学杂志,2017,26(6):682-685.
CHEN L,ZHANG C D,YIN J,et al.Analysis of Helicobacter pylori and its related antibodies in patients with gastric mucosal diseases in Qingdao[J].Chin J Gastroenterol Hepatol,2017,26(6):682-685.
[14]PETERS T M,OWEN R J,SLATER E,et al.Genetic diversity in the Helicobacter pylori cag pathogenicity island and effect on expression of anti-CagA serum antibody in UK patients with dyspepsia[J].J Clin Pathol,2001,54(3):219-223.DOI:10.1136/jcp.54.3.219.
[15]SHIOTA S,MATSUNARI O,WATADA M,et al.Serum Helicobacter pylori CagA antibody as a biomarker for gastric cancer in East-Asian countries[J].Future Microbiol,2010,5(12):1885-1893.DOI:10.2217/fmb.10.135.
[16]ALMEIDA N,DONATO M M,ROM?OZINHO J M,et al.Correlation of Helicobacter pylori genotypes with gastric histopathology in the central region of a South-European country[J].Dig Dis Sci,2015,60(1):74-85.DOI:10.1007/s10620-014-3319-8.
[17]曹文君,李敏,李慧娟.肠型胃癌和弥漫型胃癌的临床特点及预后研究[J].中国全科医学,2017,20(13):1587-1591.DOI:10.3969/j.issn.1007-9572.2017.13.012.
CAO W J,LI M,LI H J.Clinical characteristics and prognosis of intestinal-type and diffuse-type gastric cancer[J].Chinese General Practice,2017,20(13):1587-1591.DOI:10.3969/j.issn.1007-9572.2017.13.012.
[18]PARK J Y,FORMAN D,WASKITO L A,et al.Epidemiology of Helicobacter pylori and CagA-positive infections and global variations in gastric cancer[J].Toxins(Basel),2018,10(4):E163.DOI:10.3390/toxins10040163.
LU Li-juan,HAO Ning-bo,LI Xue,LIU Jian-jun,JIANG Ren-xiu,ZHANG De-sheng,WANG Rui-ling.
Effects of H.pylori Infection on Metabolism
[J]. Chinese General Practice, 2018, 21(27): 3334-3338.